Luca Healthcare

Luca Healthcare, established in 2020, is a company specializing in the development of digital endpoints within the field of digital medicine. The main application scenarios of digital endpoints cover drug efficacy evaluation in clinical trials, as digital companion products paired with drugs and devices, and for the development of standalone digital therapeutics. Luca Healthcare is committed to the development of software for disease diagnosis and treatment. Our focus is on developing and licensing clinically validated digital assessment tools, digital biomarkers, and digital therapeutics to measure and intervene in diseases and conditions within the fields of neurodegenerative diseases, cardiovascular diseases, respiratory diseases, and ophthalmic treatments. Luca Healthcare collaborates with world-class partners across different therapeutic areas and geographic regions to build a pipeline based on disease relevance and the ability to impact patients.